Skip to main content
B

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Filings indexed 450 across all filing types
Latest filing 2021-10-24 Regulatory Filings
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
Bio-Gene Commercial Agreement with Evergreen Garden Care 3 pages 265.7KB
Regulatory Filings
2021-10-24 English
Successful Allowance of New United States Patent 1
Regulatory Filings
2021-10-13 English
Notice Under ASX Listing Rule 3.13.1 1 page 220.0KB
Regulatory Filings
2021-10-11 English
Bio-Gene to Present at Australian Mosquito Control Symposium 2 pages 276.8KB
Regulatory Filings
2021-08-30 English
Appendix 4E and 2021 Annual Report 61 pages 1.7MB
Regulatory Filings
2021-08-25 English
Appendix 4G and 2021 Corporate Governance Statement 26 pages 477.6KB
Regulatory Filings
2021-08-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.